We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Image of Ruairi J Mackenzie

Ruairi J Mackenzie

Senior Science Writer

Contact Us

Ruairi started with Technology Networks in January 2018 after completing an undergraduate degree in neuroscience at the University of Edinburgh and a master’s degree in clinical neuroscience from the University of Cambridge. As senior science writer, Ruairi covers a range of scientific news and articles, with a focus on the complexities and curiosities of the brain. Ruairi also looks after search engine optimization (SEO) efforts on Technology Networks and created the site’s podcast, Opinionated Science, in 2020.

Latest Content

Ex-Rugby Players Face 15 Times Higher Risk of Motor Neuron Disease

A new study by researchers at the University of Glasgow has found that former Scottish international rugby union players have a higher risk of developing neurodegenerative diseases, including dementia, Parkinson’s disease and motor neuron disease.


Opinionated Science Episode 48: From Culture Plate to Dinner Plate –The Lingering Promise of Lab-Based Meat

This latest episode is an audio version of a cover story from our online magazine, The Scientific Observer. In that article, writer Tanaaz Khan explores the “lingering” promise of lab-based meat, investigating whether this future food will deliver for the world’s rapidly growing population.

Experimental Alzheimer’s Drug Lecanemab Slows Cognitive Decline in Clinical Trial

A significant development in Alzheimer’s disease research has been announced by the drug company Eisai. In a press release, the company said that their investigational anti-amyloid beta (Aβ) protofibril antibody lecanemab has produced modest but highly statistically significant results in trial.
Industry Insight

The Battle for Psychedelic Patents

In this article, Technology Networks speaks with Mindset Pharma CEO James Lanthier about how patents work in the fast-changing psychedelics industry, what makes a patent effective and how newer compounds stack up against natural psychedelics.


Artificial Light Is Becoming Bluer. That Has Consequences for Our Sleep.

An innovative project featuring the first composite nighttime color maps of the Earth’s surface has revealed the extent of the shift in the color spectrum that our after-dark light has undergone in the last decade.


Our Urge To Eat Fatty Foods Is Caused by a Gut-Brain Signal

The temptation of a burger or pizza has surprisingly little to do with our taste buds, finds a new study. Instead, connections between our gut and brain dictate our obsession for fatty foods, say the authors.


People Who Are Unmoved by Climate Destruction Are Less Emotional in General

New research suggests that people who are apathetic towards climate change may be more emotionally impassive in other areas of their lives.


To Hallucinate or Not: The Big Questions Facing Psychedelics at FENS 2022

One sign that the tide around psychedelic science is changing is the decision by the organizers of the recent Federation of European Neuroscience Societies (FENS) conference, the largest such neuroscience event in Europe, to carve out a slot for this burgeoning area of research. Here's a summary of what went down.

Opinionated Science Episode 47: Pig Skin Corneas and Memory Repair With Electricity

On this episode of Opinionated Science, the team investigate two technologies that suggest that take the “fi” out of “scifi”. Listen now to find out how one research group is repairing blindness with an unexpected source of cellular help, and another is using alternating electrical current to enhance memory performance.

Targeted Electrical Brain Stimulation Improves Memory in Older Adults

Four 20-minute sessions of brain stimulation are sufficient to improve short-term and long-term memory function in older adults, suggests a new study published in Nature Neuroscience